Selected article for: "care therapy and diffuse alveolar damage"

Author: Kumar, Anupam; Hadley, Ryan
Title: Respiratory Failure in a Patient with Idiopathic Pulmonary Fibrosis
  • Cord-id: 82nfkms8
  • Document date: 2019_7_24
  • ID: 82nfkms8
    Snippet: The triggers as well as etiologies for Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) are not known. AE-IPF is defined as an “acute, clinically significant respiratory deterioration characterized by evidence of new widespread alveolar abnormality typically less than 1 month’s duration. The underlying pathologic insult is classically described as diffuse alveolar damage. Ideally, infection is excluded by BAL as in the case presentation, but the severity of hypoxemia and the desi
    Document: The triggers as well as etiologies for Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) are not known. AE-IPF is defined as an “acute, clinically significant respiratory deterioration characterized by evidence of new widespread alveolar abnormality typically less than 1 month’s duration. The underlying pathologic insult is classically described as diffuse alveolar damage. Ideally, infection is excluded by BAL as in the case presentation, but the severity of hypoxemia and the desire to avoid endotracheal intubation may preclude the performance of this procedure. Supportive care is the mainstay of therapy as there are no proven therapies, although corticosteroids, cytotoxic agents and anti-coagulation have all been suggested as possible treatments. The mortality is high, particularly once invasive ventilation has been instituted.

    Search related documents:
    Co phrase search for related documents
    • absolute mortality and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • absolute mortality and low number: 1, 2
    • absolute mortality and lung cancer: 1, 2
    • absolute mortality and lung disease: 1, 2
    • absolute mortality and lung injury: 1, 2
    • absolute mortality and lung transplantation: 1
    • accelerated progression and acute ards respiratory distress syndrome: 1
    • accelerated progression and low mortality: 1
    • accurate diagnosis and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5
    • accurate diagnosis and acute exacerbation: 1, 2